Image Source: International Alliance of Patient's Organization

Agencies:

NEW YORK: Global Healthcare company Johnson & Johnson is planning to start a Phase-3 clinical trial of its COVID-19 vaccine ahead of its original schedule, potentially in late September, said a top Executive of the company.
Johnson and Johnson is in talks with the US National Institute of Health to start the late stage trial of the vaccine, ahead of the schedule, Paul Stoffels, the Chief scientific officer of the company.